Automated and Closed-Cell Therapy Process Systems Market: Current Analysis and Forecast (2022-2028)
Emphasis on Workflow (Separation, Expansion, Apheresis, Fill-Finish, Cryopreservation, and Others); Type (Stem Cell Therapy and Non-Stem Cell Therapy); Scale (Pre-Commercial/ R&D Scale and Commercial Scale); Region (North America, Europe, Asia-Pacific, Rest of the World); and Region/Country
The global automated and closed cell therapy processing systems market is expected to grow at a significant rate of around 21% during the forecast period. Cell therapy refers to placing new, healthy cells into the body to replace diseased or damaged ones, modulating the function of the patient’s cells through the expression of factors or direct interaction, or the removal of disease-causing or dysfunctional cells using immune cells. The rising investment in biomanufacturing for the development of various cellular therapy products for the treatment of chronic diseases such as cancer is the driving factor for the market growth of automated and closed-cell therapy processing. Furthermore, surging efforts in finding the treatment for incurable diseases such as Parkinson’s disease is also an important factor propelling the market. For instance, as per the WHO, Global estimates in 2019 showed over 8.5 million individuals with Parkinson’s disease. Current estimates suggest that, in 2019, Parkinson’s disease resulted in 5.8 million disability-adjusted life years, an increase of 81% since 2000, and caused 329 000 deaths, an increase of over 100% since 2000.
Miltenyi Biotec; Lonza; Fresenius Kabi AG; Danaher; BioSpherix, Ltd; Terumo Corporation; Sartorius AG; ThermoGenesis Holdings, Inc.; Cellares Inc.; and Thermo Fisher Scientific are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst workflow, separation category to witness higher CAGR during the forecast period”
Based on the workflow, the market has been categorized into separation, expansion, apheresis, fill-finish, cryopreservation, and others. Among them, the separation segment is expected to grow at the highest CAGR in the market. The separation process is an important process in cell therapy. Cell separation is required for genetic modifications, molecular analysis, creation of pure cell culture, and others. These are the factors that are responsible for the rapid growth of the segment.
“Amongst type, stem cell therapy and non-stem cell therapy category holds a dominant share in 2020”
Based on the type, the market has been categorized into stem cell therapy and non-stem cell therapy. Among them, the non-stem cell therapy segment holds a dominant share of the market. The rigorous development of non-stem cell therapy and the high success of these therapies such as immunotherapy attributed to the lucrative share of non-stem cell therapy.
“Amongst scale, diagnostic imaging centers segment to hold a higher CAGR during the forecast period”
Based on the scale, the market has been categorized into pre-commercial/ R&D scale and commercial scale. Among them, the commercial scale segment holds a higher CAGR during the forecast period. The increasing incidences of chronic and incurable diseases create the demand for feasible demand for automated cell therapy at a commercial level. Furthermore, increasing successful clinical trials of cell therapy also attributes to the rise in the release of automated and closed cell therapy at the commercial scale.
“Europe to witness the fastest growth in the market”
Europe is anticipated to witness the fastest growth during the forecast period. The major factors such as the presence of well-established healthcare and research infrastructure, along with the increasing investment of private players in revolutionizing cell therapy in the region are responsible for the fat growth of the region in the market. For instance, The Austrian deeptech startup Sarcura just secures a USD 7.46 million Seed Plus funding round to develop a next-generation cell therapy manufacturing platform.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global Automated and Closed Cell Therapy Processing Systems market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Automated and Closed Cell Therapy Processing Systems Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global automated and closed cell therapy processing systems market were the three major steps undertaken to create and analyze the adoption of automated and closed cell therapy processing systems in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global automated and closed cell therapy processing systems market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the automated and closed cell therapy processing systems market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the automated and closed cell therapy processing systems market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as workflow, type, and scale. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the automated and closed cell therapy processing systems market. Further, we conducted factor analysis using dependent and independent variables such as the workflow, type, and scale of automated and closed cell therapy processing systems. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Automated and Closed Cell Therapy Processing Systems market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global automated and closed cell therapy processing systems market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the automated and closed cell therapy processing systems market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global automated and closed cell therapy processing systems market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global automated and closed cell therapy processing systems market. Data was split into several segments & sub-segments post studying various parameters and trends in the workflow, type, and scale in the global automated and closed cell therapy processing systems market.
The main objective of the Global Automated and Closed Cell Therapy Processing
Systems Market Study
The current & future market trends of the global automated and closed cell therapy processing systems market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the automated and closed cell therapy processing systems market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of workflow, type, and scale.
- Define and analysis of the regulatory framework for the automated and closed cell therapy processing systems industry.
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
- Analyze the current and forecast market size of the automated and closed cell therapy processing systems market for the major region.
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
- Company profiles of the automated and closed cell therapy processing systems market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
